Worg Pharmaceuticals (Zhejiang) Co., Ltd. is a clinical stage biopharmaceutical company developing new treatments for allergic and autoimmune diseases.

Worg Pharmaceuticals (Zhejiang) Co., Ltd.

MetrioPharm is a clinical-stage company that develops safe and effective treatments based on first-in-class self-regulating immunomodulators for inflammatory and infectious diseases. The company's lead candidate MP1032 is an oral small molecule immune modulator targeting dysregulated mitochondrial metabolism in immune cells, aimed at reducing the side effects of corticosteroid therapy. MetrioPharm focuses on rare diseases and plans to expand indications for MP1032.

Metric
Company Name	Worg Pharmaceuticals (Zhejiang) Co., Ltd.	MetrioPharm AG
Symbol
MSH ID	COM:WORGPHARMA	COM:METRIOPHARM
Market	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services
Industry	Pharmaceuticals	Pharmaceuticals
Country	CN	DE
Stage
Employee Count
Website	worgpharma.com	metriopharm.com
LinkedIn
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

WORG

COM:WORGPHARMA

Worg Pharmaceuticals (Zhejiang) Co., Ltd.

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue